Set the Record Straight With Menopausal Hormone Therapy

February 2026

Patients will ask you about menopausal hormone therapy (MHT)...due to FDA removing certain risks (breast cancer, etc) from boxed warnings.

Note that the endometrial cancer warning will stay for estrogen-only products. Ensure a progestogen or bazedoxifene is on board for patients with a uterus...to reduce endometrial hyperplasia risk.

Be ready to discuss what’s a rumor and what’s true.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Obesity & Weight Loss Explain How New ORAL Semaglutide Stacks Up for Weight Loss
Immunizations Be Prepared With Guidance About Childhood Immunizations
Menopause Set the Record Straight With Menopausal Hormone Therapy
COPD Clear the Air With New COPD Guidelines
Fibromyalgia Lift the Fog Around Fibromyalgia Treatment
Allergic Reactions Dig Deeper if Patients Report Beta-Lactam or Sulfa Allergies
Antibiotics Review Oral Antibiotic Dosing in Patients With Obesity
NatMed Spotlight Emphasize Lifestyle Approaches to Help Manage BP

Set the Record Straight With Menopausal Hormone Therapy

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents